A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort. Radiol Oncol. 2019;53(2):219-224. Accessed October 24, 2026. https://www.radioloncol.com/index.php/ro/article/view/3222